InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
T+90 hit rate
80%
T+90 mean return
+9.3%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Hassard James, Directeur Commercial. Director active across 2 companies, notably Arrowhead Pharmaceuticals, INC.. Aggregated, 7 disclosures have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €542k. History available since 22 June 2021. The latest transaction was disclosed on 5 July 2024 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
15,000 shares@ US$19.7344.8% of flowCommon StockSEC:0000950170-24-082529:0
15,000 shares@ US$19.7345.2% of flowCommon StockSEC:0000950170-24-076871:0
1,741 shares@ US$38.1410.0% of flowCommon StockSEC:0001209191-24-005011:0
17,000 shares0Common StockSEC:0001209191-24-004612:0
14,000 shares0Common StockSEC:0001209191-23-015619:0
3,625 shares@ US$89.2250.0% of flowCommon StockSEC:0001209191-21-043137
3,625 shares@ US$89.220.0025% mcap50.0% of flowCommon StockSEC:0001209191-21-043137:0
7 of 7 declarations
About Hassard James
James Hassard is the Chief Commercial Officer at Arrowhead Pharmaceuticals, Inc. He is responsible for the company's commercial strategy, overseeing sales and business development. His expertise is essential for the growth and expansion of the organization.
